Physician profile
Michael Kuhn
NPI 1063525509
$200,980.34
in general payments reported to CMS, 2019-2025
14 companies · $117K in 2025
The $117K reported for 2025 was more than what 97% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $3,941 · 2021: $6,057 · 2022: $357 · 2023: $11K · 2024: $62K · 2025: $117K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $81K · Consulting Fee: $55K · Travel and Lodging: $26K · Honoraria: $25K · Food and Beverage: $2,273 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $81,300.00 |
| Consulting Fee | $54,834.57 |
| Travel and Lodging | $25,708.64 |
| Honoraria | $25,250.00 |
| Food and Beverage | $2,273.42 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $373.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $199,370.79 | 2020-2025 | Maci |
| Smith+Nephew, INC. | $831.35 | 2019-2023 | Ultrabutton, Spatial Frame |
| Zimmer Biomet Holdings, INC. | $502.81 | 2019-2022 | |
| Depuy Synthes Sales INC. | $39.04 | 2020 | |
| Endo Pharmaceuticals INC. | $38.02 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $34.95 | 2023 | Iovera, Zilretta |
| Djo, LLC | $25.17 | 2019 | |
| Si-Bone, INC. | $24.60 | 2020 | |
| Bioventus LLC | $21.81 | 2019 | |
| Orthofix Medical, INC. | $21.47 | 2023 | Physio-Stim |
| Heron Therapeutics, INC. | $21.46 | 2025 | Zynrelef |
| Pacira Therapeutics, INC. | $19.34 | 2019 | |
| Fidia Pharma USA INC. | $15.54 | 2024 | Triluron, Hymovis, Hyalgan |
| Gilead Sciences, INC. | $13.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kuhn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.